The role of the frontal cortex in the mouse in behavioral sensitization to amphetamine

Brain Research

Volumn 757, Issue 2, 1997, Pages 228-235

  Karler, Ralph ^a   Bedingfield, J Brent ^a   Thai, David K ^a   Calder, Larry D ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Amphetamine; Behavioral sensitization; Calcium channel blockers; Cortex; Dopamine; GABA; Glutamate; Protein synthesis inhibitor

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; AMPHETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG EFFECT; FRONTAL CORTEX; GABAERGIC SYSTEM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION; STEREOTYPY;

AMPHETAMINE; ANIMALS; BEHAVIOR, ANIMAL; BICUCULLINE; CENTRAL NERVOUS SYSTEM STIMULANTS; FRONTAL LOBE; GABA ANTAGONISTS; MALE; MICE; MICE, INBRED STRAINS; STEREOTYPED BEHAVIOR;

EID: 0030985858     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)00221-7     Document Type: Article

References (38)

1. Ashby, C.R., Jr., The Modulation of Dopaminergic Neurotransmission by Other Neurotransmitters, CRC Press, Boca Raton, FL, 1996.
2. Banks, K.E. and Gratton, A., Possible involvement of medial prefrontal cortex in amphetamine-induced sensitization of mesolimbic dopamine function, Eur. J. Pharmacol., 282 (1995) 157-167.
3. Bedingfield, J.B., Calder, L.D. and Karler, R., Comparative behavioral sensitization to stereotypy by direct and indirect dopamine agonists in CF-1 mice, Psychopharmacology, 124 (1996) 219-225.
4. Bedingfield, J.B., Calder, L.D., Thai, D.K. and Karler, R., The role of the striatum in the mouse in behavioral sensitization to amphetamine, Pharmacol. Biochem. Behav., 56 (1997) 305-310.
5. Cador, M., Bjijou, Y. and Stinus, L., Evidence of a complete independence of the neurobiological substrates for the induction and expression of behavioral sensitization to amphetamine, Neuroscience, 65 (1995) 385-395.
6. Chance, M.R.A., Aggregation as a factor influencing the toxicity of sympathomimetic amines in mice, J. Pharmacol. Exp. Ther., 87 (1946) 214-219.
7. Commins, D.L., Shaughnessy, R.A., Axt, K.J., Vosmer, G. and Seiden, L.S., Variability among brain regions in the specificity of 6-hydroxy-dopamine (6-OHDA)-induced lesions, J. Neural Transm., 77 (1989) 197-210.
8. Deutch, A.Y., The regulation of subcortical dopamine systems by the prefrontal cortex: interactions of central dopamine systems and the pathogenesis of schizophrenia, J. Neural Transm., 36 (1992) 61-89.
9. Dougherty, G.G., Jr. and Ellinwood, E.H., Jr., Chronic D-amphetamine in nucleus accumbens: lack of tolerance or reverse tolerance of locomotor activity, Life Sci., 28 (1981) 2295-2298.
10. Douglas, R.J., Koch, C., Mahowald, M., Martin, K.A.C. and Suarez, H.H., Recurrent excitation in neocortical circuits, Science, 269 (1995) 981-985.
11. Duvauchelle, C.L., Levitin, M., MacConell, L.A., Lee, L.K. and Ettenberg, A., Opposite effects of prefrontal cortex and nucleus accumbens infusions of flupenthixol on stimulant-induced locomotion and brain stimulation reward, Brain Res., 576 (1992) 104-110.
12. Ellinwood, E.H., Jr. and Balster, R.L., Rating the behavioral effects of amphetamine, Eur. J. Pharmacol., 28 (1974) 35-41.
13. Ferron, A., Thierry, A.M., Le Douarin, C. and Glowinski, J., Inhibitory influence of the mesocortical dopaminergic system on spontaneous activity or excitatory response induced from the thalamic mediodorsal nucleus in the rat medial prefrontal cortex, Brain Res., 302 (1984) 257-265.
14. Franklin, B.J. and Paxinos, G., The Mouse Brain in Stereotaxic Coordinates, Academic Press, New York, NY, 1997.
15. Graybill, A.M., Mortalla, R. and Robertson, H.A., Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum, Proc. Natl. Acad. Sci. U.S.A., 87 (1990) 6912-6916.
16. Hooks, M.S., Jones, G.H., Liem, B.J. and Justice, J.B., Jr., Sensitization and individual differences to IP amphetamine, cocaine, or caffeine following repeated intra-cranial amphetamine infusions, Ann. N.Y. Acad. Sci., 654 (1992) 444-447.
17. Kalivas, P.W. and Alesdatter, J.E., Involvement of N-Methyl-d-Aspartate receptors stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine, J. Pharmacol. Exp. Ther., 267 (1993) 486-495.
18. Kalivas, P.W. and Duffy, P., Effects of daily cocaine and morphine treatment on somatodendritic and terminal field dopamine release, J. Neurochem., 50 (1988) 1498-1504.
19. Kalivas, P.W. and Weber, W., Amphetamine injection into the ventral mesencephalon sensitizes rats to peripheral amphetamine and cocaine, J. Pharmacol. Exp. Ther., 245 (1988) 1095-1102.
20. Karler, R., Calder, L.D. and Bedingfield, J.B., A novel nicotinic-cholinergic role in behavioral sensitization to amphetamine-induced stereotypy in mice, Brain Res., 725 (1996) 192-198.
21. Karler, R., Calder, L.D., Thai, L.H. and Bedingfield, J.B., A dopaminergic-glutamatergic basis for the action of amphetamine and cocaine, Brain Res., 658 (1994) 8-14.
22. Karler, R., Calder, L.D., Thai, L.H. and Bedingfield, J.B., The Dopaminergic, glutamatergic, GABAergic basis for the action of amphetamine and cocaine, Brain Res., 671 (1995) 100-104.
23. Karler, R., Calder, L.D. and Turkanis, S.A., Calcium channel blockers and excitatory amino acids, Brain Res., 551 (1991) 331-333.
24. Karler, R., Calder, L.D. and Turkanis, S.A., DNQX blockade of amphetamine behavioral sensitization, Brain Res., 552 (1991) 295-300.
25. Karler, R., Finnegan, K.T. and Calder, L.D., Blockade of behavioral sensitization to cocaine and amphetamine by inhibitors of protein synthesis, Brain Res., 603 (1993) 19-24.
26. Karler, R., Turkanis, S.A., Partlow, L.M. and Calder, L.D., Calcium channel blockers and behavioral sensitization, Life Sci., 49 (1991) 165-170.
27. Kuczenski, R. and Leith, N.J., Chronic amphetamine: is dopamine a link in or a mediator of the development of tolerance and reverse tolerance, Pharmacol. Biochem. Behav., 15 (1981) 405-413.
28. Lipska, B.K., Jaskiw, G.E., Braun, A.R. and Weinberger, D.R., Prefrontal cortical and hippocampal modulation of haloperidol-induced catalepsy and apomorphine-induced stereotypic behaviors in the rat, Biol. Psychiatry, 38 (1995) 255-262.
29. Louilot, A., LeMoal, M. and Simon, H., Opposite influences of dopaminergic pathways to the prefrontal cortex or the septum on the dopaminergic transmission in the nucleus accumbens. An in vivo voltametric study, Neuroscience, 29 (1989) 45-56.
30. McLennan, H., Huffman, R.D. and Marshall, K.C., Patterns of excitation of thalamic neurones by amino acids and acetylcholine, Nature, 219 (1968) 387-388.
31. Murase, S., Grenhoff, J., Chouvet, G., Gonon, F.G. and Svensson, T.H., Prefrontal cortex regulates burst firing and transmitter release in rat mesolimbic dopamine neurons studied in vivo, Neurosci. Lett., 157 (1993) 53-56.
32. Pirot, S., Godbout, R., Mantz, J., Tassin, J.-P., Glowinski, J. and Thierry, A.-M., Inhibitory effects of ventral tegmental area stimulation on the activity of prefrontal cortical neurons: evidence for the involvement of both dopaminergic and gabaergic components, Neuroscience, 49 (1992) 857-865.
33. Rieder, P., Lang, K.W., Kornhuber, J. and Danielczyk, W., Glutamatergic-dopaminergic balance in the brain, Arzneimittelforschung, 42 (1992) 265-267.
34. Smith, A.D. and Bolam, J.P., The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurons, Trends Neurosci., 13 (1990) 259-265.
35. Thierry, A.-M., Tassin, J.-P. and Glowinski, J., Biochemical and electrophysiological studies of the mesocortical dopamine system. In L. Descarries, T.R. Reader and H.H. Jasper (Eds.), Monamine Innervation of Cerebral Cortex, Alan R. Liss, Inc., New York, 1984, pp. 233-261.
36. Vezina, P. and Stewart, J., Amphetamine administered to the ventral tegmental area but not to the nucleus accumbens sensitizes rats to systemic morphine: Lack of conditioned effects, Brain Res., 516 (1990) 99-106.
37. Wise, R.A. and Leeb, K., Psychomotor-stimulant sensitization: A unitary phenomenon?, Behav. Pharmacol., 4 (1993) 339-349.
38. Yoshikawa, T., Watanabe, A., Shibuya, H. and Toru, M., Involvement of the fimbria fornix in the initiation but not in the expression of methamphetamine-induced sensitization, Pharmacol. Biochem. Behav., 45 (1993) 691-695.